Market Value1,861,041,907
Total Holdings47
File Date2023-08-04
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CRWD / CrowdStrike Holdings, Inc.
LYFT / Lyft, Inc.
ALEC / Alector, Inc.
FHTX / Foghorn Therapeutics Inc.
VERA / Vera Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
MOND / Mondee Holdings, Inc.
DM / Desktop Metal, Inc.
EXAS / Exact Sciences Corporation
TCRX / TScan Therapeutics, Inc.
TNYA / Tenaya Therapeutics, Inc.
ME / 23andMe Holding Co.
OPRT / Oportun Financial Corporation
SANA / Sana Biotechnology, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
OSCR / Oscar Health, Inc.
GTLB / GitLab Inc.
PL / Planet Labs PBC
KRON / Kronos Bio, Inc.
SNOW / Snowflake Inc.
RANI / Rani Therapeutics Holdings, Inc.
FRSH / Freshworks Inc.
VERV / Verve Therapeutics, Inc.
PRME / Prime Medicine, Inc.
HLTH / Cue Health Inc.
MGTA / Magenta Therapeutics Inc
EQRX / EQRx Inc
DBTX / Decibel Therapeutics Inc
HYPR / Hyperfine, Inc.
QNCX / Quince Therapeutics, Inc.
RGEN / Repligen Corporation
BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
/ Evelo Biosciences Inc
EVLO / Evelo Biosciences, Inc.
LYEL / Lyell Immunopharma, Inc.
RAPT / RAPT Therapeutics, Inc.
PATH / UiPath Inc.
DUOL / Duolingo, Inc.
DXCM / DexCom, Inc.
ILMN / Illumina, Inc.
LSAQ / LifeSci Acquisition II Corp
RLAY / Relay Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
NVTAQ / Invitae Corporation
IVVD / Invivyd, Inc.
BHIL / Benson Hill, Inc.
SPRO / Spero Therapeutics, Inc.
HOOD / Robinhood Markets, Inc.
TSHA / Taysha Gene Therapies, Inc.
GLUE / Monte Rosa Therapeutics, Inc.